Tackling Cardiovascular Disease and Non-Communicable Diseases Through AI: TanzMED Launches Smartphone-Based Validation Study

A New Approach to Early Detection of NCDs in Tanzania

Non-communicable diseases (NCDs), particularly cardiovascular diseases, are becoming one of the leading causes of illness and death in Tanzania and across Africa. Conditions such as hypertension often develop silently, with many people remaining undiagnosed until serious complications such as stroke, heart failure, or kidney disease occur.

Routine screening remains limited due to shortages of medical equipment, healthcare workers, and access to health facilities especially in rural and underserved communities.

To address this challenge, TanzMED has launched a large-scale validation study to evaluate smartphone-based measurement of cardiovascular vital signs using artificial intelligence (AI). The study is being conducted in collaboration with the Muhimbili University of Health and Allied Sciences (MUHAS) under approved ethical protocols.

Why This Research Matters

Early detection is one of the most effective strategies for reducing the burden of cardiovascular diseases and other NCDs. However, millions of people do not regularly check their blood pressure or other vital signs because screening services are often inaccessible or inconvenient.

With the rapid growth of smartphone adoption in Tanzania, AI-powered health technologies present an opportunity to bring routine cardiovascular screening closer to where people live and work.

Before such technology can be integrated into healthcare services, it must be scientifically validated using data from the local population.

Study Objectives

The study aims to evaluate the accuracy and reliability of smartphone-based cardiovascular measurements by comparing AI-generated results with clinically approved medical devices.

Approximately 6,000 participants will be enrolled across Tanzania to assess the technology under real-world conditions.

The validation will include:

  • Blood Pressure

  • Heart Rate

  • Oxygen Saturation (SpO₂)

  • Heart Rate Variability (HRV)

The research will also assess performance across different age groups, genders, skin tones, body characteristics, and environmental conditions to ensure the technology performs reliably within African populations.

Supporting Better Prevention of Cardiovascular Diseases

If successfully validated, smartphone-based cardiovascular screening could help transform preventive healthcare by enabling more frequent and accessible health monitoring.

Potential benefits include:

  • Earlier identification of individuals at risk of hypertension and cardiovascular disease.

  • Improved monitoring of people living with chronic NCDs.

  • Increased access to routine screening in underserved communities.

  • Better linkage between community screening and healthcare facilities.

  • More timely clinical intervention before serious complications develop.

Rather than replacing healthcare professionals, the technology is intended to support earlier detection and encourage people to seek appropriate medical care.

Building Evidence for Responsible AI in Healthcare

Artificial intelligence has significant potential to improve healthcare delivery, but responsible implementation requires strong scientific evidence.

This study will generate locally validated evidence on the performance of AI-powered cardiovascular screening within Tanzanian populations. The findings will contribute to future regulatory processes and support responsible integration of digital health technologies into routine healthcare.

Ethical Research and Participant Protection

The study has received ethical approval through MUHAS and follows established research standards. Participation is voluntary, informed consent is obtained from all participants, and personal health information is managed in accordance with research ethics and applicable data protection requirements.

Advancing the Fight Against NCDs

Cardiovascular diseases and other non-communicable diseases continue to place growing pressure on health systems throughout Africa. Innovation alone is not enough—solutions must be evidence-based, clinically validated, and designed for the populations they serve.

Through this validation study, TanzMED is contributing to the development of accessible, AI-powered technologies that can strengthen early detection, improve prevention, and support better cardiovascular health for communities across Tanzania and beyond.

Published time